Skip to main content

Case Management Conference To Review Valsartan Recall Claims

Case Management Conference To Review Valsartan Recall Claims

Case Management Conference To Review Valsartan Recall Claims

Introduction

The U.S. District Judge presiding over Valsartan litigation has scheduled a meeting on June 26, with lawyers involved in federal Valsartan recall lawsuits. During this meeting, parties are expected to discuss procedures designed to advance claims brought by individuals nationwide who received versions of the blood pressure drug that were contaminated with cancer-causing chemicals.

Currently, there are five dozen product liability lawsuits pending in the federal court system against various generic drug manufacturers, each raising similar claims that generic valsartan pills were distributed for years with cancer-causing impurities, including NDMA and NDEA, which appear to be a by-product of the drug manufacturing process.

On June 24, defendants and plaintiffs filed statement outlining the proposed agenda items of the upcoming conference. According to plaintiffs’ statement, it indicated that the proposed plaintiffs’ fact sheet form submitted by defendants would be overly burdensome, and the issue is expected to be a significant part of this conference. The defendants’ statement indicated that they hope to iron out disagreements and finalize the standardized fact sheets before the July 24 conference, which will help facilitate the exchange of information about each of the valsartan recall claims.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.